Status:
COMPLETED
The Effects of Geranylgeraniol (GG) Sourced From Annatto on Sexual Health
Lead Sponsor:
Applied Science & Performance Institute
Conditions:
Sexual Health
Libido
Eligibility:
All Genders
30-49 years
Phase:
NA
Brief Summary
The purpose of this study will be to examine the effectiveness of Geranylgeraniol supplementation on sexual health function in males and females following an 8-week dose escalation intervention. The s...
Detailed Description
The purpose of this study will be to examine the effectiveness of Geranylgeraniol supplementation on sexual health function in males and females following an 8-week dose escalation intervention. The s...
Eligibility Criteria
Inclusion
- Males and Females age 30-49 years old
- Males scoring 27-36 on the Aging Males Symptoms scale
- Willing to sign the Informed Consent
- English literate
Exclusion
- Cardiovascular, neurological, metabolic, or endocrine disease
- Drink heavily (\>7 and \>14 drinks per week for women and men, respectively)
- Smoke
- Renal, hematological, or hepatic disorder
- Psychiatric disorder, depression
- Peptic ulcer
- Any malignancy
- Thrombosis
- Undergone surgery that affects digestion and absorption
- Hypo- or hypertensive
- Undergoing hormone replacement therapy
- Using hormone boosting supplements (herbal or synthetic)
- Using drugs that are anti-diabetic, anti-platelet, anti-coagulant, beta blockers, or used to treat ED
- Pregnant or trying to conceive, currently breastfeeding, or have breastfeed within the prior 3 months
- Have participated in a clinical trial within the past 6 months
Key Trial Info
Start Date :
February 6 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 9 2022
Estimated Enrollment :
83 Patients enrolled
Trial Details
Trial ID
NCT05258513
Start Date
February 6 2022
End Date
December 9 2022
Last Update
December 29 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Applied Science and Performance Institute
Tampa, Florida, United States, 33607